Cann Group Ltd (CAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.000x

Based on the latest financial reports, Cann Group Ltd (CAN) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.00K ≈ $-7.78K USD) by net assets (AU$34.16 Million ≈ $24.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Cann Group Ltd market capitalisation for the company's overall valuation and market capitalisation.

Cann Group Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Cann Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cann Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cann Group Ltd ranked by their cash flow conversion efficiency. Explore CAN cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
RKEC Projects Limited
NSE:RKEC
0.014x
Gibb River Diamonds Ltd
AU:GIB
-1.410x
Foresight Solar Fund Ltd
LSE:FSFL
0.015x
MPC Energy Solutions NV
OL:MPCES
0.002x
Stellar AfricaGold Inc.
V:SPX
-0.152x
THREED CAPITAL INC.
F:B5K3
N/A
Genesis Resources Ltd
AU:GES
-0.764x
CASA DE BUCOVINA-CLUB DE MUNTE
RO:BCM
-0.009x

Annual Cash Flow Conversion Efficiency for Cann Group Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. View Cann Group Ltd share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-2.77 Million
≈ $-1.96 Million
AU$-9.64 Million
≈ $-6.82 Million
3.475x +418.57%
2024-06-30 AU$13.92 Million
≈ $9.85 Million
AU$-15.19 Million
≈ $-10.74 Million
-1.091x -183.08%
2023-06-30 AU$59.26 Million
≈ $41.93 Million
AU$-22.84 Million
≈ $-16.16 Million
-0.385x -60.11%
2022-06-30 AU$84.90 Million
≈ $60.07 Million
AU$-20.43 Million
≈ $-14.46 Million
-0.241x -6.15%
2021-06-30 AU$91.87 Million
≈ $65.01 Million
AU$-20.83 Million
≈ $-14.74 Million
-0.227x +21.40%
2020-06-30 AU$61.07 Million
≈ $43.21 Million
AU$-17.62 Million
≈ $-12.47 Million
-0.288x -200.42%
2019-06-30 AU$77.30 Million
≈ $54.69 Million
AU$-7.42 Million
≈ $-5.25 Million
-0.096x -119.63%
2018-06-30 AU$85.87 Million
≈ $60.76 Million
AU$-3.75 Million
≈ $-2.66 Million
-0.044x +72.12%
2017-06-30 AU$14.66 Million
≈ $10.37 Million
AU$-2.30 Million
≈ $-1.63 Million
-0.157x +78.75%
2016-06-30 AU$1.69 Million
≈ $1.20 Million
AU$-1.25 Million
≈ $-882.14K
-0.738x +25.57%
2015-06-30 AU$648.33K
≈ $458.73K
AU$-642.74K
≈ $-454.78K
-0.991x --

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$4.70 Million
AU$6.64 Million AUD
Market Cap Rank
#28799 Global
#1549 in Australia
Share Price
AU$0.00
Change (1 day)
-20.00%
52-Week Range
AU$0.00 - AU$0.02
All Time High
AU$3.98
About

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.